Results for tag: "Mibefradil"

Mibefradil is a calcium channel blocker used to treat hypertension and angina pectoris. It is a member of the dihydropyridine class of calcium channel blockers, which are used to reduce the workload of the heart and lower blood pressure. Mibefradil is also used to treat arrhythmias, or irregular heartbeats. It works by blocking the influx of calcium into the cells of the heart and blood vessels, which helps to reduce the force of contraction of the heart and relax the blood vessels. Mibefradil is a relatively new drug in the cardiovascular market, and is not widely used. It is not as effective as some of the other calcium channel blockers, and has been associated with some side effects. However, it is still used in some cases, particularly when other drugs are not effective. Companies in the Mibefradil market include Pfizer, Merck, Sanofi, and Novartis. Show Less Read more